top of page

Technology Platform

Non-Invasive Hemodynamic + Biomarker Monitoring — Redefining Early Detection

Non-Invasive Venous Monitoring Platform

Non-Invasive Venous Monitoring.png

Core Innovation

Patented platform for non-invasive venous hemodynamic monitoring and early detection of venous congestion.

Regulatory Differentiation

World's first FDA-cleared solution for non-invasive central venous pressure (CVP) assessment

One sensor replacing two invasive procedures:

  • Central Venous Pressure 

  • Jugular Vein Distension

  • Jugular Venous Oxygen Saturation

Clinical Replacement

Continuous, non-invasive insight into venous physiology—previously only accessible via invasive catheterization

Continuous Cardiac Output + Venous Return

Cardiac Output.png

Core Innovation

Patented approach to continuous, non-invasive assessment of both cardiac output and venous return—providing a complete view of circulatory dynamics.

Physiological Differentiation

Moves beyond single-parameter monitoring by assessing the balance between output and return

  • Cardiac Output 

  • Venous Return 

  • Real-time hemodynamic balance

Clinical Insight

One platform enabling deeper understanding of circulation::

  • Detects mismatch between output and return

  • Identifies early congestion despite stable output

  • Provides insight into preload and fluid responsiveness

Wearable Transdermal BNP 

Untitled design (15).png

Novel Sensing Approach

Patented nano-sensor for transdermal biomarker detection to provide early detection of heart failure decompensation

Clinical Advancement

Enables frequent, low-cost BNP measurements outside the hospital

Adds biochemical insight to hemodynamic monitoring.

Clinical Value

Combining physiology (CVP, JVD, SjvO₂) with biomarkers (BNP) enables a complete view of heart failure status.

bottom of page